Cargando…

HLA Class II Genotype Does Not Affect the Myelin Responsiveness of Multiple Sclerosis Patients

Background: When aiming to restore myelin tolerance using antigen-specific treatment approaches in MS, the wide variety of myelin-derived antigens towards which immune responses are targeted in multiple sclerosis (MS) patients needs to be taken into account. Uncertainty remains as to whether the mye...

Descripción completa

Detalles Bibliográficos
Autores principales:	Derdelinckx, Judith, Nkansah, Irene, Ooms, Naomi, Van Bruggen, Laura, Emonds, Marie-Paule, Daniëls, Liesbeth, Reynders, Tatjana, Willekens, Barbara, Cras, Patrick, Berneman, Zwi N., Cools, Nathalie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7766454/ https://www.ncbi.nlm.nih.gov/pubmed/33348629 http://dx.doi.org/10.3390/cells9122703

Ejemplares similares

Antigen-Specific Treatment Modalities in MS: The Past, the Present, and the Future
por: Derdelinckx, Judith, et al.
Publicado: (2021)

Immunomodulatory Effects of 1,25-Dihydroxyvitamin D(3) on Dendritic Cells Promote Induction of T Cell Hyporesponsiveness to Myelin-Derived Antigens
por: Lee, Wai-Ping, et al.
Publicado: (2016)

Cells to the Rescue: Emerging Cell-Based Treatment Approaches for NMOSD and MOGAD
por: Derdelinckx, Judith, et al.
Publicado: (2021)

Neuromyelitis Optica Spectrum Disorders in Africa: A Systematic Review
por: Musubire, Abdu Kisekka, et al.
Publicado: (2021)

Tolerogenic Dendritic Cells Induce Apoptosis-Independent T Cell Hyporesponsiveness of SARS-CoV-2-Specific T Cells in an Antigen-Specific Manner
por: Van Delen, Mats, et al.
Publicado: (2022)

Shuttling Tolerogenic Dendritic Cells across the Blood–Brain Barrier In Vitro via the Introduction of De Novo C–C Chemokine Receptor 5 Expression Using Messenger RNA Electroporation
por: De Laere, Maxime, et al.
Publicado: (2018)

Into the Moment: Does Mindfulness Affect Biological Pathways in Multiple Sclerosis?
por: Willekens, Barbara, et al.
Publicado: (2018)

Improved detection of MOG antibody-associated transverse myelitis with 18F-FDG-PET: a case report
por: Daems, F., et al.
Publicado: (2022)

Optimizing Dendritic Cell-Based Immunotherapy: Tackling the Complexity of Different Arms of the Immune System
por: Van Brussel, Ilse, et al.
Publicado: (2012)

To the Brain and Back: Migratory Paths of Dendritic Cells in Multiple Sclerosis
por: De Laere, Maxime, et al.
Publicado: (2018)

Made to Measure: Patient-Tailored Treatment of Multiple Sclerosis Using Cell-Based Therapies
por: Wens, Inez, et al.
Publicado: (2021)

Neuroendocrine Immunoregulation in Multiple Sclerosis
por: Deckx, Nathalie, et al.
Publicado: (2013)

Clinical and immunological control of experimental autoimmune encephalomyelitis by tolerogenic dendritic cells loaded with MOG-encoding mRNA
por: Derdelinckx, Judith, et al.
Publicado: (2019)

Dendritic Cells: Cellular Mediators for Immunological Tolerance
por: Chung, Chun Yuen J., et al.
Publicado: (2013)

Clinical importance of extended second field high‐resolution HLA genotyping for kidney transplantation
por: Senev, Aleksandar, et al.
Publicado: (2020)

Regulatory T Cells and Human Disease
por: Cools, Nathalie, et al.
Publicado: (2007)

Association of HLA Class I Genotypes With Severity of Coronavirus Disease-19
por: Shkurnikov, Maxim, et al.
Publicado: (2021)

A Microfluidic In Vitro Three-Dimensional Dynamic Model of the Blood–Brain Barrier to Study the Transmigration of Immune Cells
por: Meena, Megha, et al.
Publicado: (2022)

Short-term cultured, interleukin-15 differentiated dendritic cells have potent immunostimulatory properties
por: Anguille, Sébastien, et al.
Publicado: (2009)

Increased Transendothelial Transport of CCL3 Is Insufficient to Drive Immune Cell Transmigration through the Blood–Brain Barrier under Inflammatory Conditions In Vitro
por: De Laere, Maxime, et al.
Publicado: (2017)

Beyond the Magic Bullet: Current Progress of Therapeutic Vaccination in Multiple Sclerosis
por: Willekens, Barbara, et al.
Publicado: (2018)

Transmigration across a Steady-State Blood–Brain Barrie Induces Activation of Circulating Dendritic Cells Partly Mediated by Actin Cytoskeletal Reorganization
por: Meena, Megha, et al.
Publicado: (2021)

Sensitive detection of human papillomavirus type 16 E7-specific T cells by ELISPOT after multiple in vitro stimulations of CD8(+ )T cells with peptide-pulsed autologous dendritic cells
por: Cools, Nathalie, et al.
Publicado: (2006)

Human Tears Reveal Insights into Corneal Neovascularization
por: Zakaria, Nadia, et al.
Publicado: (2012)

Cryopreserved vitamin D(3)-tolerogenic dendritic cells pulsed with autoantigens as a potential therapy for multiple sclerosis patients
por: Mansilla, María José, et al.
Publicado: (2016)

HLA class I and II genotype of the NCI-60 cell lines
por: Adams, Sharon, et al.
Publicado: (2005)

Class IIa HDACs in myelination
por: Velasco-Aviles, Sergio, et al.
Publicado: (2018)

Comparison of exome-based HLA class I genotyping tools: identification of platform-specific genotyping errors
por: Kiyotani, Kazuma, et al.
Publicado: (2017)

High-Throughput High-Resolution Class I HLA Genotyping in East Africa
por: Koehler, Rebecca N., et al.
Publicado: (2010)

Interleukin-12p70 Expression by Dendritic Cells of HIV-1-Infected Patients Fails to Stimulate gag-Specific Immune Responses
por: Van Gulck, Ellen, et al.
Publicado: (2012)

Genetic Diversity of HLA Class I and Class II Alleles in Thai Populations: Contribution to Genotype-Guided Therapeutics
por: Satapornpong, Patompong, et al.
Publicado: (2020)

The Pre-Transplant Non-HLA Antibody Burden Associates With the Development of Histology of Antibody-Mediated Rejection After Kidney Transplantation
por: Senev, Aleksandar, et al.
Publicado: (2022)

Rapid Exercise-Induced Mobilization of Dendritic Cells Is Potentially Mediated by a Flt3L- and MMP-9-Dependent Process in Multiple Sclerosis
por: Deckx, Nathalie, et al.
Publicado: (2015)

Association of HLA Class I Genotype with Mortality in Patients with Diabetes Mellitus and COVID-19
por: Shkurnikov, M. Yu., et al.
Publicado: (2023)

12 Weeks of Combined Endurance and Resistance Training Reduces Innate Markers of Inflammation in a Randomized Controlled Clinical Trial in Patients with Multiple Sclerosis
por: Deckx, Nathalie, et al.
Publicado: (2016)

Non-classical HLA-class I expression in serous ovarian carcinoma: Correlation with the HLA-genotype, tumor infiltrating immune cells and prognosis
por: Andersson, Emilia, et al.
Publicado: (2015)

Class II HLA Genotype Association With First-Phase Insulin Response Is Explained by Islet Autoantibodies
por: Koskinen, Maarit K, et al.
Publicado: (2017)

Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomics
por: Nagler, Adi, et al.
Publicado: (2021)

Tolerogenic dendritic cell-based treatment for multiple sclerosis (MS): a harmonised study protocol for two phase I clinical trials comparing intradermal and intranodal cell administration
por: Willekens, Barbara, et al.
Publicado: (2019)

HLA class II transgenic mice: the chance to unravel the basis of HLA class II associations with disease
Publicado: (1994)

Cannot write session to /tmp/vufind_sessions/sess_dg8qm0crp3a2ophtd9pf0aulg7